基于临床疗效及Th1/Th2、Th17/Treg炎性平衡变化探讨痛泻要方治疗溃疡性结肠炎的机制

被引:47
作者
厉启芳 [1 ]
刘善军 [1 ]
景德怀 [1 ]
刘国霞 [2 ]
朱亚珍 [3 ]
孙冰 [3 ]
章洪华 [3 ]
于斌 [3 ]
机构
[1] 济宁医学院附属医院
[2] 济宁市兖州区中医院
[3] 济宁医学院
关键词
肝郁脾虚证; 溃疡性结肠炎; 炎性平衡; T细胞; 痛泻要方;
D O I
10.13192/j.issn.1000-1719.2018.08.001
中图分类号
R259 [现代医学内科疾病];
学科分类号
100201 [内科学];
摘要
目的:观察痛泻要方加减治疗肝郁脾虚型溃疡性结肠炎的临床疗效以及其对T细胞Th1/Th2、Th17/Treg介导的炎性细胞因子平衡的影响。方法:筛选符合肝郁脾虚证型的溃疡性结肠炎入院及门诊患者62例,随机分为对照组和治疗组。对照组采用柳氮磺胺吡啶片进行常规治疗,治疗组在常规方案的基础上采用痛泻要方加减进行治疗。2周为1个疗程,连续干预2个疗程。治疗前后对患者临床症状和疗效进行评价,采集患者外周血通过ELISA方法检测血清IL-4、IL-10、IL-17和IFN-γ的含量。之后计算每个样本治疗前后IFN-γ/IL-4和IL-17/IL-10的比值。结果:在治疗有效率方面,对照组为41.94%,治疗组的有效率为67.74%,组间比较差异具有统计学意义(P<0.01)。与治疗前相比,两组治疗后临床症状积分均呈现降低趋势,差异都具有统计学意义,与对照组治疗后相比,治疗组治疗后临床症状积分降低趋势更明显,差异具有统计学意义(P<0.01)。与治疗前相比,两组治疗后IL-4和IL-10的含量升高明显,IL-17和IFN-γ的含量降低,差异均具有统计学意义(P<0.01)。比值分析发现,治疗后两组IFN-γ/IL-4和IL-17/IL-10的比值均呈现降低趋势,与对照组治疗后相比,治疗组降低趋势明显,差异具有统计学意义(P<0.05)。结论:痛泻要方联合常规西医治疗能够明显缓解肝郁脾虚型溃疡性结肠炎的临床症状,机制与其能够促使Th1/Th2、Th17/Treg介导的炎性平衡朝炎性抑制方向转化相关。
引用
收藏
页码:1569 / 1572
页数:4
相关论文
共 20 条
[1]
Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation [J].
Magnusson, M. K. ;
Brynjolfsson, S. F. ;
Dige, A. ;
Uronen-Hansson, H. ;
Borjesson, L. G. ;
Bengtsson, J. L. ;
Gudjonsson, S. ;
Ohman, L. ;
Agnholt, J. ;
Sjovall, H. ;
Agace, W. W. ;
Wick, M. J. .
MUCOSAL IMMUNOLOGY, 2016, 9 (01) :171-182
[2]
Cyclosporine A Regulates Pro-Inflammatory Cytokine Production in Ulcerative Colitis [J].
Steiner, Stefanie ;
Daniel, Carolin ;
Fischer, Anika ;
Atreya, Imke ;
Hirschmann, Simon ;
Waldner, Maximilian ;
Neumann, Helmut ;
Neurath, Markus ;
Atreya, Raja ;
Weigmann, Benno .
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2015, 63 (01) :53-63
[3]
Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease [J].
Jiang, Wenyu ;
Su, Jiewen ;
Zhang, Xiaofei ;
Cheng, Xiuqin ;
Zhou, Jun ;
Shi, Ruihua ;
Zhang, Hongjie .
INFLAMMATION RESEARCH, 2014, 63 (11) :943-950
[4]
Multigene Analysis Unveils Distinctive Expression Profiles of Helper T-cell–related Genes in the Intestinal Mucosa that Discriminate Between Ulcerative Colitis and Crohn?s Disease.[J].Yoichiro Iboshi;Kazuhiko Nakamura;Eikichi Ihara;Tsutomu Iwasa;Hirotada Akiho;Naohiko Harada;Makoto Nakamuta;Ryoichi Takayanagi.Inflammatory Bowel Diseases.2014, 6
[5]
Epidemiology of inflammatory bowel disease: Focus on Asia [J].
Ng, Siew C. .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2014, 28 (03) :363-372
[6]
Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces [J].
Rubtsov, Yuri P. ;
Rasmussen, Jeffrey P. ;
Chi, Emil Y. ;
Fontenot, Jason ;
Castelli, Luca ;
Ye, Xin ;
Treuting, Piper ;
Siewe, Lisa ;
Roers, Axel ;
Henderson, William R., Jr. ;
Muller, Werner ;
Rudensky, Alexander Y. .
IMMUNITY, 2008, 28 (04) :546-558
[7]
中医药治疗溃疡性结肠炎机制研究进展 [J].
王师英 ;
胡鸿毅 ;
林江 .
辽宁中医杂志, 2016, 43 (11) :2452-2456
[8]
健脾解毒化瘀方灌肠对溃疡性结肠炎患者T细胞亚群的研究 [J].
章小平 ;
查安生 ;
丁小丽 ;
邹晓华 .
中华中医药学刊 , 2016, (02) :396-398
[9]
Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P [J].
Yin, Yue ;
Zhong, Lei ;
Wang, Jian-Wei ;
Zhao, Xue-Ying ;
Zhao, Wen-Jing ;
Kuang, Hai-Xue .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (15) :4536-4546
[10]
参苓白术散对溃疡性结肠炎小鼠肠道调节性T细胞免疫调节作用 [J].
李晓冰 ;
崔利宏 ;
陈玉龙 ;
展俊平 ;
谢忠礼 ;
朱艳琴 ;
沈小君 ;
李瑞琴 .
中成药, 2014, (06) :1295-1297